Last reviewed · How we verify

NCT04561479

Pulmonary Rehabilitation in Patients With Chronic Fibrotic Hypersensitivity Pneumonitis

Status unknown NA Last updated 23 September 2020
What this trial tests

NA trial testing Pulmonary Rehabilitation in Hypersensitivity Pneumonitis in 30 participants. Status unknown.

Timeline
1 June 2021
Primary endpoint
1 February 2022
1 June 2023

Quick facts

Lead sponsorGazi University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposesupportive care
Enrollment30
Start date1 June 2021
Primary completion1 February 2022
Estimated completion1 June 2023

Drugs / interventions tested

Conditions studied

Sponsor

Gazi University

Who can join

Adults 18 to 80, any sex, with Hypersensitivity Pneumonitis or Extrinsic Allergic Alveolitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim is to evaluate exercise capacity, respiratory functions, respiratory and peripheral muscle strength, inspiratory muscle endurance, physical activity level, quality of life, fatigue, dyspnea, anxiety, depression and investigate the impact of 24-session pulmonary rehabilitation training on these parameters in patients with chronic fibrotic hypersensitivity pneumonitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Pulmonary Rehabilitation

Trials testing the same drug.

Other recruiting trials for Hypersensitivity Pneumonitis

Currently open trials in the same condition.

Other Gazi University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04561479.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing